Role of HLA class II alleles in Korean patients with IDDM

Cited 9 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorH C Lee-
dc.contributor.authorH Ikegami-
dc.contributor.authorT Fugisana-
dc.contributor.authorT Ogihara-
dc.contributor.authorS W Park-
dc.contributor.authorY S Chung-
dc.contributor.authorJ O Park-
dc.contributor.authorE J Lee-
dc.contributor.authorS K Lim-
dc.contributor.authorK R Kim-
dc.contributor.authorK B Huh-
dc.contributor.authorYong Sung Kim-
dc.contributor.authorDae Sil Lee-
dc.contributor.authorD H Kim-
dc.date.accessioned2017-04-19T08:53:40Z-
dc.date.available2017-04-19T08:53:40Z-
dc.date.issued1996-
dc.identifier.issn0168-8227-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/3876-
dc.description.abstractMHC associations with IDDM in the Korean population were studied to investigate genetic susceptibility to this disorder. The frequencies of HLA-DR3, -DR4 and -DR9 were significantly higher in diabetic patients. However, the frequency of DR2 was significantly decreased in diabetic patients. DQA1*0301 and DQA1*0501 were positively and DQA1*0102 and DQA1*0201 negatively associated with IDDM. DQB1*0301 and DQB1*0601 were negatively associated with IDDM. Heterodimers DQA1*0301-DQB1*0201, DQA1*0501-DQB1*0201 and DQA1*0501-DQB1*0302 were positively associated and DQA1*0102-DQB1*0601 negatively associated with IDDM. The frequencies of DR3-DQB1*0301-DQB1*0201 and -DQA1*0501-DQB1*0201 were significantly higher in diabetic patients. The frequencies of DR4-DQA1*0301 DQB1*0201 and DR9-DQA1*0301-DQB1*0303 were significantly higher in diabetic patients. The presence of non-aspartic acid at position 57 of the DQβ-chain was not associated with susceptibility to IDDM. However, the frequency of Arg 52 homozygotes was significantly higher in diabetic patients. These results suggest a role of the MHC molecule and also suggest racial differences in susceptibility to IDDM even within the Asian populations.-
dc.publisherElsevier-
dc.titleRole of HLA class II alleles in Korean patients with IDDM-
dc.title.alternativeRole of HLA class II alleles in Korean patients with IDDM-
dc.typeArticle-
dc.citation.titleDiabetes Research and Clinical Practice-
dc.citation.number0-
dc.citation.endPage15-
dc.citation.startPage9-
dc.citation.volume31-
dc.contributor.affiliatedAuthorYong Sung Kim-
dc.contributor.affiliatedAuthorDae Sil Lee-
dc.contributor.alternativeName-
dc.contributor.alternativeNameIkegami-
dc.contributor.alternativeNameFugisana-
dc.contributor.alternativeNameOgihara-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName김용성-
dc.contributor.alternativeName이대실-
dc.contributor.alternativeName-
dc.identifier.bibliographicCitationDiabetes Research and Clinical Practice, vol. 31, pp. 9-15-
dc.identifier.doi10.1016/0168-8227(96)01200-4-
dc.subject.keywordHLA-
dc.subject.keywordHuman leukocyte antigen-
dc.subject.keywordIDDM-
dc.subject.keywordInsulin-dependent diabetes mellitus-
dc.subject.keywordPCR-
dc.subject.keywordPolymerase chain reaction-
dc.subject.localHLA-
dc.subject.localHuman leukocyte antigen-
dc.subject.localIDDM-
dc.subject.localInsulin-dependent diabetes mellitus-
dc.subject.localPolymerase Chain Reaction-
dc.subject.localPolymerase chain reaction-
dc.subject.localPolymerase chain reaction (PCR)-
dc.subject.localPCR-
dc.subject.localPCR, polymerase chain reaction-
dc.subject.localpolymerase chain reaction-
dc.subject.localPolymerase Chain Reaction-
dc.subject.localPolymerase chain reaction-
dc.subject.localPolymerase chain reaction (PCR)-
dc.subject.localPCR-
dc.subject.localPCR, polymerase chain reaction-
dc.subject.localpolymerase chain reaction-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.